Leadership Administrative Core
Leadership Administrative Core
批准号:
10599819
负责人:
SHERRY ANN MCKEE
金额:
$46.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-03-10 至 2025-02-28
关键词:
Advanced DevelopmentAlcohol consumptionAwardBiosensorClinical ResearchCollectionCommunitiesConsultationsDarknessDataData CollectionDevelopmentDoctor of PhilosophyEducationEducation and OutreachEnsureEnvironmentFDA approvedFundingGoalsHealth PersonnelHuman ResourcesInfrastructureInstitutionLeadLeadershipMentorshipOffice of Administrative ManagementPharmaceutical PreparationsPilot ProjectsPoliciesPrincipal InvestigatorPublic HealthResearchResearch PersonnelResourcesRoleSex DifferencesSideStructureTeacher Professional DevelopmentTherapeuticTrainingTranslatingTranslationsWomanWorkaddictionalcohol abuse therapyalcohol use disordercareerdesigndrinkingfaculty supportgender differenceimprovedmeetingsoutreachpreclinical studysexsynergismtranslational pipelinetranslational potential
中文摘要
领导力管理核心的目的是提供全面的跨学科和
Yale-Score的翻译科学计划和协调,因为它制定了适合性别的
以“成瘾的阴暗面”为指导的酒精使用障碍的治疗
框架。具体地说,核心将通过其结构和资源:1)管理持续的概念性
整合中心人员,以利用耶鲁大学的协同效应和翻译机会-
SCORE,2)支持耶鲁-SCORE内部以及与其他耶鲁大学开展新的合作研究
其他机构的中心和分数,3)定期组织规划会议,以促进活力
研究人员就新的科学发现及其对性行为适宜性的影响进行交流
药物开发,4)促进项目、试点和核心工作,通过财政和
行政监督,征集、审查和资助有功试点,监督研究成果分配--
相关资源;为核心电池的设计提供投入,并收集生物传感器数据以
最大限度地提高中心的科学成果,以及5)教育和告知我们的社区,并发挥
机构、地区和国家资源,以激进性和酒精使用的研究。我们的方法是
旨在确保项目负责人、调查人员、合作者和受训者在一个一体化的
创建协调的跨学科翻译团队工作的科学环境,专注于
推进AUD性适宜治疗的发展。核心的目标将会实现
通过以下具体目标。目标1:提供综合科学研究规划和监督
在耶鲁-SCORE的首席调查员、副主任和执行委员会中,
来自外部科学咨询委员会的咨询。目标2:确保财政和行政监督
耶鲁分数线项目和试点项目。目标3:成为机构、区域和国家资源,以
通过以下方式活跃和促进T1到T4翻译过程中与酒精使用有关的性别差异的研究
提供专家咨询,支持教师培训奖项,利用国家性和酒精数据
用于为治疗和政策提供信息,并通过向当地社区、区域、
和全国观众。
英文摘要
The purpose of the Leadership Administrative Core is to provide the overall interdisciplinary and
translational scientific planning and coordination for the Yale-SCORE, as it develops sex-appropriate
therapeutics for the treatment of alcohol use disorders (AUD) using the ‘dark side of addiction’ as a guiding
framework. Specifically the Core, through its structure and resources, will: 1) manage the ongoing conceptual
integration of Center personnel to capitalize on the synergies and translational opportunities of the Yale-
SCORE, 2) support the development of new collaborative research within the Yale-SCORE and with other Yale
Centers and SCOREs at other institutions, 3) organize regular planning meetings to promote dynamic
exchange among investigators regarding new scientific findings and their implications for sex-appropriate
medications development, 4) facilitate the work of the Projects, Pilots, and Cores through fiscal and
administrative oversight, solicit, review and fund meritorious Pilot Projects, oversee the distribution of research-
related resources; provide input into the design of a core battery, and the collection of biosensor data to
maximize the scientific yield of the Center, and 5) educate and inform our communities and function as an
institutional, regional, and national resource to invigorate the study of sex and alcohol use. Our approach is
designed to ensure that the Project Leads, investigators, collaborators, and trainees operate in an integrated
scientific environment that creates a coordinated interdisciplinary translational team effort, focused on
advancing the development of sex-appropriate treatment for AUD. The goals of the Core will be accomplished
through the following specific aims. AIM 1: Provide integrated scientific research planning and oversight
among the Yale-SCORE’s Principal Investigator, Deputy Director, and Executive Committee, with targeted
consultation from the External Scientific Advisory Board. AIM 2: Ensure fiscal and administrative oversight to
the Yale-SCORE Projects and Pilot Projects. AIM 3: Be an institutional, regional, and national resource to
invigorate and galvanize the study of sex differences in relation to alcohol use across T1 to T4 translation by
providing expert consultation, supporting faculty training awards, leveraging national data on sex and alcohol
use to inform treatment and policy, and by providing outreach and dissemination to local community, regional,
and national audiences.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phase 2 study examining efficacy and mechanisms of combining varenicline and guanfacine for smoking cessation in women and men
-
批准号:10398931
-
项目类别:
-
资助金额:$79.5万
-
财政年份:2020
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Leadership Administrative Core
-
批准号:10357879
-
项目类别:
-
资助金额:$67.38万
-
财政年份:2020
-
负责人:SHERRY ANN MCKEE
-
依托单位:
PROJECT 1: Targeting stress-reactivity and noradrenergic mechanisms for sex-appropriate alcohol use disorder treatment.
-
批准号:10357882
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2020
-
负责人:SHERRY ANN MCKEE
-
依托单位:
PROJECT 1: Targeting stress-reactivity and noradrenergic mechanisms for sex-appropriate alcohol use disorder treatment.
-
批准号:10599822
-
项目类别:
-
资助金额:$27.17万
-
财政年份:2020
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Yale-SCORE NIMH Data Archive
-
批准号:10347940
-
项目类别:
-
资助金额:$10.81万
-
财政年份:2020
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Phase 2 study examining efficacy and mechanisms of combining varenicline and guanfacine for smoking cessation in women and men
-
批准号:10192689
-
项目类别:
-
资助金额:$79.5万
-
财政年份:2020
-
负责人:SHERRY ANN MCKEE
-
依托单位:
YALE-SCORE ON SEX DIFFERENCES IN ALCOHOL USE DISORDER
-
批准号:10357878
-
项目类别:
-
资助金额:$167.5万
-
财政年份:2020
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Phase 2 study examining efficacy and mechanisms of combining varenicline and guanfacine for smoking cessation in women and men
-
批准号:9886547
-
项目类别:
-
资助金额:$75.5万
-
财政年份:2020
-
负责人:SHERRY ANN MCKEE
-
依托单位:
YALE-SCORE ON SEX DIFFERENCES IN ALCOHOL USE DISORDER
-
批准号:10599817
-
项目类别:
-
资助金额:$167.5万
-
财政年份:2020
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Does Guanfacine, an alpha2 adrenergic agonist, attenuate stress-induced drinking?
-
批准号:8631313
-
项目类别:
-
资助金额:$37.46万
-
财政年份:2014
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Does Guanfacine, an alpha2 adrenergic agonist, attenuate stress-induced drinking?
-
批准号:9212067
-
项目类别:
-
资助金额:$37.46万
-
财政年份:2014
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Does Guanfacine, an alpha2 adrenergic agonist, attenuate stress-induced drinking?
-
批准号:8794388
-
项目类别:
-
资助金额:$36.34万
-
财政年份:2014
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Phase-II Clinical Trial Evaluating Guanfacine for Smoking Cessation
-
批准号:8841703
-
项目类别:
-
资助金额:$80.69万
-
财政年份:2013
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Phase-II Clinical Trial Evaluating Guanfacine for Smoking Cessation: Administrative Supplement
-
批准号:8815787
-
项目类别:
-
资助金额:$10.9万
-
财政年份:2013
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Phase-II Clinical Trial Evaluating Guanfacine for Smoking Cessation
-
批准号:8675821
-
项目类别:
-
资助金额:$71.2万
-
财政年份:2013
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Phase-II Clinical Trial Evaluating Guanfacine for Smoking Cessation
-
批准号:8577631
-
项目类别:
-
资助金额:$65.58万
-
财政年份:2013
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Yale SCOR on Gender-Sensitive Treatment for Tobacco Dependence
-
批准号:8345893
-
项目类别:
-
资助金额:$122.98万
-
财政年份:2012
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Sex-Appropriate Treatment Development for Alcohol Use Disorders
-
批准号:9794638
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2012
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Yale SCOR on Gender-Sensitive Treatment for Tobacco Dependence
-
批准号:8870320
-
项目类别:
-
资助金额:$117.02万
-
财政年份:2012
-
负责人:SHERRY ANN MCKEE
-
依托单位:
Does doxazosin attenuate stress-induced smoking and improve clinical outcomes?
-
批准号:8292606
-
项目类别:
-
资助金额:$24.91万
-
财政年份:2012
-
负责人:SHERRY ANN MCKEE
-
依托单位:
海外基金